5 pending office actions • 3 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLLINGTON, JERMELE M | 1 | 86.0% | -15.3% |
| NGUYEN, JOHN P | 1 | 44.3% | +41.3% |
| SCHLIENTZ, LEAH H | 1 | 41.9% | +38.9% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 51.1% | +42.9% |
| HENLEY III, RAYMOND J | 1 | 83.5% | +2.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18888510 | ELECTRICAL IMPEDANCE SPTROSCOPY FOR NON-DESTRUCTIVE, REAL-TIME, TRACKING OF RELATIVE WATER CONTENT AND STRESS RESPONSE IN PLANTS | HOLLINGTON, JERMELE M | — |
| 17767173 | EARLY MANAGEMENT, MITIGATION and PREVENTION OF SEPSIS and SEPSIS-LIKE SYNDROMES, INCLUDING NEO-NATAL ARDS DUE TO INFECTION, INJURY or IATROGENESIS | HENLEY III, RAYMOND J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17927917 | NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING | SCHLIENTZ, LEAH H | 89d overdue |
| 18073852 | DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS | NGUYEN, JOHN P | — |
| 17801486 | TREATMENT FOR CHEMOBRAIN | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| Client (Assignee) | Pending OAs |
|---|---|
| UNM RAINFOREST INNOVATIONS | 2 |
| Yale University | 2 |
| Ophirex, Inc. | 1 |
| Art Unit | Apps |
|---|---|
| 2858 | 1 |
| 1619 | 1 |
| 1618 | 1 |
| 1622 | 1 |
| 1629 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18888510 | ELECTRICAL IMPEDANCE SPTROSCOPY FOR NON-DESTRUCTIVE, REAL-TIME, TRACKING OF RELATIVE WATER CONTENT AND STRESS RESPONSE IN PLANTS | UNM RAINFOREST INNOVATIONS | HOLLINGTON, JERMELE M | 2858 | §103 | Non-Final OA | — | Pending | Sep 18, 2024 |
| 18073852 | DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS | Yale University | NGUYEN, JOHN P | 1619 | §103 | Non-Final OA | — | Pending | Dec 02, 2022 |
| 17927917 | NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING | UNM RAINFOREST INNOVATIONS | SCHLIENTZ, LEAH H | 1618 | §103 | Non-Final OA | 89d overdue | Pending | Nov 28, 2022 |
| 17801486 | TREATMENT FOR CHEMOBRAIN | Yale University | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103 | Final Rejection | — | Pending | Aug 22, 2022 |
| 17767173 | EARLY MANAGEMENT, MITIGATION and PREVENTION OF SEPSIS and SEPSIS-LIKE SYNDROMES, INCLUDING NEO-NATAL ARDS DUE TO INFECTION, INJURY or IATROGENESIS | Ophirex, Inc. | HENLEY III, RAYMOND J | 1629 | §103 | Non-Final OA | — | Pending | Apr 07, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial